OSAM
LXRX icon

O'Shaughnessy Asset Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

O'Shaughnessy Asset Management’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,415
Closed -$7K – 1941
2021
Q3 		$7K Sell
1,415
-5,132
-78% -$21.1K ﹤0.01% 2249
2021
Q2 		$30K Sell
6,547
-25,475
-80% -$123K ﹤0.01% 1734
2021
Q1 		$188K Buy
32,022
+20,225
+171% +$140K ﹤0.01% 954
2020
Q4 		$40K Sell
11,797
-3,792
-24% -$7.23K ﹤0.01% 1294
2020
Q3 		$22K Buy
15,589
+8,272
+113% +$14.7K ﹤0.01% 1237
2020
Q2 		$15K Buy
7,317
+5,391
+280% +$10.6K ﹤0.01% 1191
2020
Q1 		$4K Buy
+1,926
New +$5.73K ﹤0.01% 1102

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

O'Shaughnessy Asset Management's LXRX Position: Q4 2021 in Review

O'Shaughnessy Asset Management sold out of Lexicon Pharmaceuticals (LXRX) in Q4 2021, closing a stake of 1,415 shares — an estimated $7K sold.

O'Shaughnessy Asset Management first reported a position in LXRX in Q1 2020 and held it in 7 quarters. The position peaked at $188K in Q1 2021. 110 funds tracked by Wall St. Rank hold LXRX as of Q4 2021.

  • O'Shaughnessy Asset Management reported no remaining Lexicon Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 1,415 Lexicon Pharmaceuticals shares in Q4 2021, an estimated $7K.
  • O'Shaughnessy Asset Management first reported a position in Lexicon Pharmaceuticals in Q1 2020 and held it in 7 quarters.
  • O'Shaughnessy Asset Management's Lexicon Pharmaceuticals position peaked at $188K in Q1 2021.
  • 110 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q4 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.